BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10435250)

  • 1. Implications of managed care for methadone treatment. Findings from five case studies in New York State.
    Zarkin GA; Dunlap LJ
    J Subst Abuse Treat; 1999; 17(1-2):25-35. PubMed ID: 10435250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of welfare reform on methadone treatment: policy lessons from service providers in New York city.
    Benoit E; Young R; Magura S; Staines GL
    Subst Use Misuse; 2004; 39(13-14):2355-90. PubMed ID: 15603008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone maintenance and state Medicaid managed care programs.
    McCarty D; Frank RG; Denmead GC
    Milbank Q; 1999; 77(3):341-62, 274. PubMed ID: 10526548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
    J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention in publicly funded methadone maintenance treatment in two Western States.
    Deck D; Carlson MJ
    J Behav Health Serv Res; 2005; 32(1):43-60. PubMed ID: 15632797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature discharge from methadone treatment: patient perspectives.
    Reisinger HS; Schwartz RP; Mitchell SG; Peterson JA; Kelly SM; O'Grady KE; Marrari EA; Brown BS; Agar MH
    J Psychoactive Drugs; 2009 Sep; 41(3):285-96. PubMed ID: 19999682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy.
    Weinrich M; Stuart M
    JAMA; 2000 Mar; 283(10):1343-8. PubMed ID: 10714738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to treatment-related and support services in methadone treatment programs.
    Berkman ND; Wechsberg WM
    J Subst Abuse Treat; 2007 Jan; 32(1):97-104. PubMed ID: 17175403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment as harm reduction, defunding as harm maximization: the case of methadone maintenance.
    Rosenbaum M; Washburn A; Knight K; Kelley M; Irwin J
    J Psychoactive Drugs; 1996; 28(3):241-9. PubMed ID: 8895109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinic-based treatment for opioid dependence: a qualitative inquiry.
    McMurphy S; Shea J; Switzer J; Turner BJ
    Am J Health Behav; 2006; 30(5):544-54. PubMed ID: 16893317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of time and money prices on treatment attendance for methadone maintenance clients.
    Borisova NN; Goodman AC
    J Subst Abuse Treat; 2004 Jan; 26(1):345-52. PubMed ID: 14698798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for opioid dependence: quality and access.
    Rounsaville BJ; Kosten TR
    JAMA; 2000 Mar; 283(10):1337-9. PubMed ID: 10714736
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comprehensive care of drug addiction during a 5-year period at the methadone center in Prague].
    Popov P; Becka J; Wilczek H
    Vnitr Lek; 2003 Nov; 49(11):851-8. PubMed ID: 14689681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone treatment providers' views of drug court policy and practice: a case study of New York State.
    Csete J; Catania H
    Harm Reduct J; 2013 Dec; 10():35. PubMed ID: 24308548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinton administration plans to expand access to methadone.
    McCarthy M
    Lancet; 1998 Oct; 352(9135):1206. PubMed ID: 9777853
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methadone, maintenance program and reduction of drug abuse. An expanding practice].
    Tremblay M
    Perspect Infirm; 2005; 2(3):40-1. PubMed ID: 15686211
    [No Abstract]   [Full Text] [Related]  

  • 18. Financing and cost of standard and enhanced methadone treatment.
    Bradley CJ; French MT; Rachal JV
    J Subst Abuse Treat; 1994; 11(5):433-42. PubMed ID: 7869464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a 'microecologic technique' to study crime incidents around methadone maintenance treatment centers - a response: The journal publishes both invited and unsolicited letters.
    Gupta R; Sarkar S; Balhara YP
    Addiction; 2012 Oct; 107(10):1883. PubMed ID: 22831569
    [No Abstract]   [Full Text] [Related]  

  • 20. Methadone treatment centers and crime: the journal publishes both invited and unsolicited letters.
    Mooney G
    Addiction; 2012 Nov; 107(11):2051-2; author reply 2052-3. PubMed ID: 23039754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.